With 2 billion people worldwide without access to medicine, this editorial looks at some of the initiatives within the pharmaceutical industry that have made strides towards improving this number.
The article features findings from the Foundation's 10-year analysis on how the pharmaceutical industry has performed on global health goals. Jayasree K. Iyer is also quoted explaining why the developing world must be a priority:
"As the world works toward achieving the Sustainable Development Goals by 2030, continuing to expand access to medicine must be a top priority, particularly for people living in low and middle-income countries, which together account for 83% of all people. Pharma companies, as innovators and producers of medicines and vaccines, are key partners for advancing universal health coverage and improving immunisation rates.”